ArticleClinical and experimental immunology2016

Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.

G-X Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.